论文部分内容阅读
Pexiganan用于糖尿病足感染治疗的两项Ⅲ期试验结果公布美国Access Pharmaceuticals制药公司于2008年12月17日宣布,Pexiganan用于局部治疗轻度糖尿病足感染的两项Ⅲ期试验结果得以公
Pexiganan Two Trials for Diabetic Foot Infections Announced Results Access Pharmaceuticals Pharmaceuticals announced on December 17, 2008 that two Phase III trials of Pexiganan for topical treatment of mild diabetic foot infections were available